The effect of progestin therapy in advanced and recurrent endometrial cancer: A systematic review and meta‐analysis

BACKGROUND: Fifteen percent of patients with endometrial cancer (EC) have advanced stage disease or develop a recurrence. Progestins have been applied as systemic treatment for decades, but there is limited evidence on response prediction with biomarkers and toxicity. OBJECTIVES: To review the respo...

Descripción completa

Detalles Bibliográficos
Autores principales: van Weelden, Willem Jan, Birkendahl, Philine B., Lalisang, Roy I., IntHout, Joanna, Kruitwagen, Roy F. P. M., Romano, Andrea, Pijnenborg, Johanna M. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Systematic Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100186/
https://www.ncbi.nlm.nih.gov/pubmed/36264251
http://dx.doi.org/10.1111/1471-0528.17331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100186/
https://www.ncbi.nlm.nih.gov/pubmed/36264251
http://dx.doi.org/10.1111/1471-0528.17331

Ejemplares similares